- Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. Ingle, J.N., Suman, V.J., Rowland, K.M., Mirchandani, D., Bernath, A.M., Camoriano, J.K., Fishkin, P.A., Nikcevich, D.A., Perez, E.A. J. Clin. Oncol. (2006)